亿帆医药,002019,收入构成,报告日期,2020-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
高分子材料,14068,-- ,14068,--,8.86%
原料药,99520,16900,82619,83.02%,52.04%
医药,167472,105405,62067,37.06%,39.1%

亿帆医药,002019,收入构成,报告日期,2019-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药,366264,233439,132825,36.26%,55.5%
高分子材料,28848,20791,8057,27.93%,3.37%
原料药,123572,25115,98458,79.68%,41.14%

亿帆医药,002019,收入构成,报告日期,2019-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
高分子,14580,10489,4091,28.06%,3.73%
医药,178363,117266,61096,34.25%,55.66%
原料药,58836,14266,44570,75.75%,40.61%

亿帆医药,002019,收入构成,报告日期,2018-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
原料药,126673,41715,84959,67.07%,41.61%
医药,307665,195693,111972,36.39%,54.85%
高分子材料,28841,21614,7227,25.06%,3.54%

亿帆医药,002019,收入构成,报告日期,2018-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药,134704,86766,47938,35.59%,42.48%
原料药,83182,21972,61210,73.59%,54.24%
高分子,14662,10960,3702,25.25%,3.28%

亿帆医药,002019,收入构成,报告日期,2017-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
高分子材料,18698,-- ,18698,--,7.13%
原料药,199139,40778,158362,79.52%,60.36%
医药,219492,132671,86821,39.56%,33.09%
其他(补充),-- ,1507,-1507,--,-0.57%

亿帆医药,002019,收入构成,报告日期,2017-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
高分子,8642,5867,2775,32.11%,2.79%
原料药,77037,20097,56940,73.91%,57.22%
医药,100009,60212,39798,39.79%,39.99%

亿帆医药,002019,收入构成,报告日期,2016-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
高分子材料,19891,12721,7170,36.05%,4.05%
原料药,112586,30701,81885,72.73%,46.22%
医药,217983,129884,88098,40.42%,49.73%

亿帆医药,002019,收入构成,报告日期,2016-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,1175,124,1051,89.47%,1.26%
高分子,9054,6014,3040,33.58%,3.64%
医药原料及中间体,56235,18097,38139,67.82%,45.66%
医药,106704,65410,41293,38.7%,49.44%

亿帆医药,002019,收入构成,报告日期,2015-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
高分子,21176,15060,6117,28.89%,6.22%
医药原料及中间体,56597,35005,21592,38.15%,21.95%
医药,165719,95078,70642,42.63%,71.83%

亿帆医药,002019,收入构成,报告日期,2015-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,578,64,514,88.98%,1.06%
医药原料及中间体,30759,19628,11130,36.19%,23.02%
医药,79160,45357,33803,42.7%,69.92%
高分子,11314,8416,2899,25.62%,6%

亿帆医药,002019,收入构成,报告日期,2014-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
高分子材料,7652,5534,2118,27.68%,3.15%
其他(补充),658,14,643,97.81%,0.96%
医药原料及中间体,14151,6865,7286,51.49%,10.83%
医药,146037,88831,57206,39.17%,85.06%

亿帆医药,002019,收入构成,报告日期,2014-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),199,-- ,199,--,0.96%
高分子材料,9918,7549,2369,23.88%,11.43%
精细化工产品,33651,15502,18149,53.93%,87.6%

亿帆医药,002019,收入构成,报告日期,2013-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),253,-- ,253,--,1.29%
活性炭,-- ,-- ,0,--,0%
高分子材料,18463,14095,4367,23.65%,22.2%
精细化工产品,51087,36037,15049,29.46%,76.51%

亿帆医药,002019,收入构成,报告日期,2013-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),84,-- ,84,--,0.94%
活性炭,-- ,-- ,0,--,0%
高分子材料,7419,5855,1564,21.09%,17.41%
精细化工产品,26166,18829,7337,28.04%,81.65%

亿帆医药,002019,收入构成,报告日期,2012-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),4595,-- ,4595,--,24.67%
活性炭,84,190,-106,-125.84%,-0.57%
高分子材料,14776,11878,2898,19.62%,15.56%
精细化工产品,44964,33728,11236,24.99%,60.33%

亿帆医药,002019,收入构成,报告日期,2012-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),4339,-- ,4339,--,40.23%
其他,84,190,-106,-125.84%,-0.98%
高分子材料,4822,3983,840,17.41%,7.78%
精细化工,22918,17204,5714,24.93%,52.97%

亿帆医药,002019,收入构成,报告日期,2011-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),739,-- ,739,--,6.32%
活性炭,883,1352,-469,-53.14%,-4.01%
高分子材料,8194,7752,442,5.39%,3.78%
保健品、药品,-- ,-- ,0,--,0%
精细化工产品,39758,28776,10982,27.62%,93.91%

亿帆医药,002019,收入构成,报告日期,2011-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),536,0,0,100%,0%
活性炭,530,857,-327,-61.61%,-6.7%
高分子材料,2309,2331,-22,-0.96%,-0.45%
保健品、药品,-- ,-- ,0,--,0%
精细化工产品,20107,14882,5225,25.99%,107.15%

亿帆医药,002019,收入构成,报告日期,2008-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他,222,271,-49,-22.26%,-0.25%
保健品,647,372,275,42.58%,1.38%
精细化工,46768,26965,19803,42.34%,98.87%

亿帆医药,002019,收入构成,报告日期,2008-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他,35,33,2,4.75%,0.01%
保健品销售,504,173,331,65.77%,2.17%
生化产品销售,28840,13927,14913,51.71%,97.81%

亿帆医药,002019,收入构成,报告日期,2007-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他,51,49,3,4.96%,0.01%
保健品,835,240,595,71.28%,1.22%
精细化工,75428,27239,48188,63.89%,98.77%

亿帆医药,002019,收入构成,报告日期,2007-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他,12,8,4,31.73%,0.02%
保健品、医药制剂,503,180,323,64.19%,1.61%
精细化工,32851,13097,19753,60.13%,98.37%

亿帆医药,002019,收入构成,报告日期,2006-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
抵消,-8402,-8236,-167,1.98%,-1.37%
其他,12,11,1,6.71%,0.01%
保健品代理销售收入,166,-- ,166,--,1.36%
保健品销售,1419,461,958,67.51%,7.89%
生化产品销售,41446,30259,11187,26.99%,92.11%

亿帆医药,002019,收入构成,报告日期,2006-09-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
生物药品制造业,1742,553,1189,68.24%,14.13%
有机化学产品制造业,23990,16767,7223,30.11%,85.87%

亿帆医药,002019,收入构成,报告日期,2006-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
生物药品制造业,1254,379,0,69.79%,0%
有机化学产品制产业,16032,11710,0,26.96%,0%

亿帆医药,002019,收入构成,报告日期,2006-03-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他行业,2,1,1,39.68%,0.03%
保健品行业,718,218,501,69.66%,18.95%
生化行业,8818,6679,2140,24.27%,81.02%

亿帆医药,002019,收入构成,报告日期,2005-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
抵销,-2192,-2192,0,0%,0%
其他,47,33,14,30.24%,100%
保健品销售,426,123,0,71.22%,0%
生化产品销售,28651,20909,0,27.02%,0%

亿帆医药,002019,收入构成,报告日期,2005-09-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
化学药品制剂制造业,21,16,5,25.36%,0.28%
有机化学产品制造业,7288,5359,1929,26.47%,99.72%

亿帆医药,002019,收入构成,报告日期,2005-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
化学药品制剂制造业,59,50,0,15.7%,0%
有机化学产品制造,13342,8873,0,33.49%,0%

亿帆医药,002019,收入构成,报告日期,2004-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
有机化学产品制造业,24506,16422,7946,32.99%,100%

亿帆医药,002019,收入构成,报告日期,2004-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
有机化学产品制造业,11352,6832,0,39.82%,0%

亿帆医药,002019,收入构成,报告日期,2003-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
左内酯销售,100,39,60,60.61%,1.09%
D-泛醇销售,1736,988,748,43.08%,13.44%
D-泛酸钙销售,15841,11087,4754,30.01%,85.47%

亿帆医药,002019,收入构成,报告日期,2002-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
维生素销售,500,480,0,4.09%,0%
左内酯销售,32,12,0,62.28%,0%
D-泛醇销售,379,267,0,29.68%,0%
D-泛酸钙销售,12183,8013,0,34.23%,0%

亿帆医药,002019,收入构成,报告日期,2001-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
D-泛酸钙销售,9134,5482,3651,39.98%,100%


